This paper reviews recent evidence on two prevalent course patterns of
major depressive illness arising from dysthymic and cyclothymic tempe
ramental substrates. The first pattern, known as ''double depression,'
' typically begins insidiously in childhood or adolescence, pursues a
low-grade intermittent course, and is complicated by superimposed high
ly recurrent major depressions. Patients with this pattern respond to
TCAs, MAOIs (classical and reversible), and SSRIs (of which the best c
urrent evidence is for fluoxetine). The second pattern, that of ''cycl
othymic depression,'' is represented by bipolar II and related soft bi
polar disorders; it pursues a more fluctuating course from onset in ju
venile or early adult years, and appears susceptible to rapid cycling
upon tricyclic antidepressant administration. For patients exhibiting
the latter pattern, bupropion, MAOIs, and low-dose SSRIs all seem bene
ficial, but should be preferably used in conjunction with lithium or o
ther mood stabilizers such as valproate; thyroid augmentation is parti
cularly relevant to these cyclothymic depressions. Practical and suppo
rtive psychotherapeutic approaches would be useful for double depressi
ve patients, while psychoeducation and attention to rhythmopathy would
be more relevant for those with cyclothymic depressions. Conjugal and
other interpersonal strains should also be addressed in both affectiv
e subtypes. The evidence reviewed does not support the commonly held b
elief that depressions associated with ''personality'' disorders respo
nd suboptimally to treatment. On the contrary, the temperamental dysre
gulation underlying depressive subtypes defined by course appears resp
onsive-even overresponsive-to a new spectrum of thymoleptic agents. Th
ese considerations underscore the close link between innovative temper
ament-based classifications of depressive illness and emerging clinica
l management strategies with thymoleptic agents and psychosocial inter
ventions.